Log In
Print this Print this

Piromelatine (Neu-P11)

  Manage Alerts
Collapse Summary General Information
Company Neurim Pharmaceuticals Ltd.
DescriptionMelatonin MT1 and MT2 receptor agonist and serotonin (5-HT1A) and 5-HT1D receptor agonist
Molecular Target Melatonin MT1 receptor ; Serotonin (5-HT1A) receptor
Mechanism of ActionMelatonin MT1 receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationInsomnia
Indication DetailsTreat primary insomnia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today